| oxaliplatin / Generic mfg. |
GASTRANOX, NCT00718354: Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT |
|
|
| Completed | 3 | 740 | RoW | Enoxaparin, Standard Chemotherapy, Some commonly prescribed Chemotherapy regimens in India are:, - Epirubicin + Cisplatin + Capecitabine, - Capecitabine + Oxaliplatin, - Docetaxil + Carboplatin, - Epirubicin + Cisplatin + Fluorouracil, - Docetaxil + Cisplatin with G/C/S/F support, - Epirubicin + Cisplatin + Flourouracil, - Docetaxil + Cisplatin + Flourouracil | Thrombosis Research Institute | Gastric Cancer, Gastroesophageal Cancer | 01/10 | 08/10 | | |
| Completed | 3 | 1035 | RoW | Capecitabine, Oxaliplatin | Sanofi, Hoffmann-La Roche | Stomach Neoplasms | 11/12 | 11/12 | | |
| Terminated | 3 | 574 | Europe | epirubicin, oxaliplatin, capecitabine (EOX), EOX + panitumumab | Royal Marsden NHS Foundation Trust | Oesophago-gastric Cancer | 02/13 | 02/13 | | |
|
|
|
|
|
|
NCT01748851: XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) |
|
|
| Terminated | 3 | 42 | RoW | XELOX, Xeloda, FOLFOX, 5-FU | Dong-A University Hospital | Gastric Carcinoma Stage IV | 09/14 | 09/14 | | |
SOPP, NCT01671449: S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer |
|
|
| Completed | 3 | 338 | RoW | S-1, TS-1, Cisplatin, Oxaliplatin, Pleoxin | Min-Hee Ryu | Gastric Cancer | 10/14 | 10/15 | | |
NCT01662869 / 2012-001402-23: A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer |
|
|
| Completed | 3 | 564 | US, Canada, Europe, RoW | 5-Fluoruracil, Folinic acid, Onartuzumab, MetMAb, RO5490258, PRO143966, Oxaliplatin, Placebo | Hoffmann-La Roche, Genentech, Inc. | Gastric Cancer | 12/15 | 12/15 | | |
|
|
|
NCT01824459: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients |
|
|
| Completed | 3 | 576 | RoW | S-1, Oxaliplatin, Cisplatin | Sun Yat-sen University, Taiho Pharmaceutical Co., Ltd. | Gastric Cancer | 12/18 | 12/18 | | |
NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer |
|
|
| Recruiting | 3 | 620 | RoW | Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy | Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou | Gastric Cancer | 12/23 | 12/25 | | |
